TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
181,475,000
|
165,242,000
|
114,063,000 |
| Financial expenses |
543,000
|
1,523,000
|
466,000 |
| Earnings before taxes |
82,755,000
|
-20,662,000
|
23,021,000 |
| EBITDA |
41,721,000
|
29,551,000
|
25,717,000 |
| Total assets |
365,256,000
|
270,063,000
|
316,065,000 |
| Current assets |
37,216,000
|
33,759,000
|
31,955,000 |
| Current liabilities |
24,273,000
|
24,951,000
|
20,259,000 |
| Equity capital |
310,550,700
|
211,508,200
|
261,541,700 |
| - share capital |
2,054,000
|
2,054,000
|
2,054,000 |
| Employees (average) |
7,248
|
6,875
|
6,814 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
85.0%
|
78.3%
|
82.7% |
| Turnover per employee |
25,038
|
24,035
|
16,740 |
| Profit as a percentage of turnover |
45.6%
|
-12.5%
|
20.2% |
| Return on assets (ROA) |
22.8%
|
-7.1%
|
7.4% |
| Current ratio |
153.3%
|
135.3%
|
157.7% |
| Return on equity (ROE) |
26.6%
|
-9.8%
|
8.8% |
| Change turnover |
16,233,000
|
51,179,000
|
6,783,000 |
| Change turnover % |
10%
|
45%
|
6% |
| Chg. No. of employees |
373
|
61
|
181 |
| Chg. No. of employees % |
5%
|
1%
|
3% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.